The elevated expression of PGRN can subsequently modulate G2/M stage and CDK4 to promote cell cycle progression, leading to the proliferation and migration of gastric cancer cells (Wang et al., 2011; Yang et al., 2017; Ren et al., 2022). Here, GRN is linked to gastric cancer.